Evidence map›Paper›PMID 36059455›Full record

ArticleFrontiers in immunology2022

Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease.

Zento Yamada, Junko Nishio, Kaori Motomura, Satoshi Mizutani, Soichi Yamada, Tetuo Mikami, Toshihiro Nanki

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. NanoSHP099-Targeted SHP2 Inhibition Boosts Ly6CAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zento YamadaDepartment of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.
Junko NishioDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Kaori MotomuraDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Satoshi MizutaniDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Soichi YamadaDivision of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan.
Tetuo MikamiDepartment of Pathology, Toho University School of Medicine, Tokyo, Japan.
Toshihiro NankiDepartment of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan.
Toho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibrosing interstitial lung disease (ILD) develops due to the impaired reparative processes following lung tissue damage. Cellular senescence has been reported to contribute to the progression of fibrosis. However, the mechanisms by which these senescent cells initiate and/or drive the progression of lung tissue fibrosis are not yet fully understood. We demonstrated that p21

Indexed as

Alveolar Epithelial CellsPulmonary FibrosisAnimalsBleomycinCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21FibrosisMiceTransforming Growth Factor betaBleomycinCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Transforming Growth Factor betaIL-6interstitial lung diseaseinterstitial macrophagesp16p21senescence-associated secretary phenotypetype 2 alveolar epithelial cell

Identifiers

PMID36059455
PMCPMC9434111
OpenAlexW4292481019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.